Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2023-12-18 DOI:10.1080/21645515.2023.2294579

Mengting Shi, Dongchen Sun, Xilun Ma, Jiaqing Liu, Yaxiong Zhang, Tingting Liu, Xueyuan Chen, Silang Mo, Yuanyuan Zhao, Li Zhang

引用次数: 0

Abstract

Leptomeningeal metastasis (LM) of nasopharyngeal carcinoma (NPC) is rare and associated with a poor prognosis. Immune checkpoint inhibitors (ICIs) have been the standard first-line treatment for me...

查看原文本刊更多论文

病例报告：化疗免疫疗法治疗晚期鼻咽癌的脑转移灶

鼻咽癌（NPC）的全身转移（LM）非常罕见，而且预后较差。免疫检查点抑制剂（ICIs）一直是治疗鼻咽癌的标准一线疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.